Brief: Endo Announces Divestiture Of International Pharmaceuticals Business
11/03/2025 10:46
March 11 (Reuters) - Endo Inc NDOI.PK: ENDO ANNOUNCES DIVESTITURE OF INTERNATIONAL PHARMACEUTICALS BUSINESS ENDO INC - TO DIVEST INTERNATIONAL PHARMACEUTICALS BUSINESS FOR UP TO $99 MILLION ENDO INC - DEAL INCLUDES $84 MILLION UPFRONT CASH PAYMENT AND $15 MILLION IN MILESTONE PAYMENTS Source text: ID:nCNWPlYBBa Further company coverage: NDOI.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo
See all newsBrief: Mallinckrodt, Endo Announce Planned Leadership Team For Merged Company
Brief: Endo To Report First Quarter 2025 Financial Results On May 7, 2025
Deals of the day-Mergers and acquisitions
Corrected: Deals of the day-Mergers and acquisitions
To Pay Endo $80.2 Million Termination Fee If Deal Is Terminated Under Certain Conditions